Introduction
Diaminomaleonitrile (DAMN) and its N-substituted derivatives are very useful compounds in heterocyclic synthesis.
1,2 Recently we designed novel approaches to β-(1,2,3-triazol-1-yl)-α-amino acid derivatives, 3 β-(imidazol-1-yl)-α-amino acid derivatives, 4 As an extension of these investigations we describe here further functionalization of the [1, 2, 3] triazolo [1,5-a] pyrazine system and the synthesis of some [1, 2, 3] triazolo [1,5-a] [1, 2, 4] triazolo [5,1-c] pyrazines. We focused on the formation of 1,2,4-triazole ring fused to the N(5)=C(4)(NH 2 ) unit of the amine 1, 5 ( Figure 1 ), by the general synthetic method that use N,Ndimethylformamide dimethyl acetal (DMFDMA), hydroxylamine hydrochloride, and polyphosphoric acid (PPA) as the main required reagents, 7, 8 thinking that this procedure could be extended to the heterocyclic system 1. 
Figure 1
This transformation seemed to be of interest since it would represent the first entry to this tricyclic system. Besides, a competitive cyclization involving the amino and cyano groups might also be possible giving another tricyclic system. This type of reaction, but with the two groups in the same ring, had been observed in some heterocycles, for example in 2-amino-3-cyanopyridine. 9, 10 In addition, [1, 2, 3] triazoloazines with a bridgehead nitrogen atom exhibit valence tautomerism and could suffer lost of dinitrogen forming azine derivatives, via the corresponding diazomethylazines.
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Results and Discussion
Thus, reaction of the amine 1 with DMFDMA in refluxing chloroform afforded the expected amidine 2, which on subsequent treatment with excess hydroxylamine hydrochloride in presence of triethylamine gave compound 3. Heating 3 with PPA gave the tricyclic derivative 4. Treatment of 3 with acetic anhydride at room temperature resulted in the formation of the monoacetate 5, whereas reaction under reflux gave the diacetate 6. Attempts to form the 1,2,4-triazole ring by another procedure, 15 heating 5 in water failed, giving the amidoxime 7 as the main product, indicating that hydrolysis of the acetylated formamidoxime moiety took place. Compound 7 was also prepared by heating 1 with excess of hydroxylamine hydrochloride and triethylamine in ethanol. The amidoxime moiety of 4 was cyclized into an 1,2,4-oxadiazole ring. This conversion was carried out by treatment of 4 with acetic anhydride at room temperature to give the acetate 8, followed by subsequent cyclization to 9 by heating in water, (Scheme 2).
The structures of all new compounds were elucidated on the basis of 1 H, 13 C and 2D
(HMQC, HMBC) NMR spectroscopy and HRMS data. The chemical shifts attributed to the C-3, C-4, C-6, CO, CN, and C(NH 2 )=NO carbons in the triazolopyrazine derivatives and to the C-2, C-5, C-10, C-10a, C-10b, CO, and C(N)=NO carbons in the tricyclic derivatives were distinguished on the basis of their HMBC connectivities. For example, the HMBC spectrum of 3 showed correlations between the H-7 proton and the C-3a, C-6, and CO carbons, between the NH 2 protons and the C-3 carbon, between the OH proton (in the amidoxime moiety at the C-3 position) and the C-NH 2 carbon, between the CH proton and the C-4 carbon, between the NH proton (in the amidoxime moiety at the C-4 position) and the C-3a, C-4 and C-6 carbons, and between the OCH 2 protons and the C-6 carbon. 
Conclusions
We have succeeded in the preparation of some derivatives of the [1, 2, 3] 
Experimental Section
General Procedures. Melting points were determined on a Kofler micro hot stage and are uncorrected. IR spectra were recorded on a Bio-Rad FTS 3000MX spectrophotometer. NMR spectra were recorded on a Bruker AVANCE DPX-300 spectrometer (300 MHz for 1 H and 75.5
MHz for 13 C) in DMSO-d 6 with TMS as an internal standard. The coupling constants (J) are given in Hz. MS spectra were obtained on a VG-Analytical AutoSpec Q instrument. Compound 1 was prepared as described in the literature. 5 Commercial compounds were used without purification as supplied by merchants. Ethyl 4-(acetyloxyiminomethylamino)-3-(aminohydroxyiminomethyl)[1,2,3]triazolo[1,5-a] 
